Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
NCT ID: NCT00802633
Last Updated: 2014-02-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
80 participants
INTERVENTIONAL
2008-11-30
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Effectiveness of TissuePatchTM in Preventing Postoperative Pancreatic Fistula
NCT05404256
Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery
NCT00307515
Ligasure II: Standard Stapling Versus Ligasure
NCT01349426
Closure of Fasciotomy Wounds: A Prospective, Observational Study of a Continuous External Tissue Expander
NCT01171534
Evaluation of the Cryopreserved Amniotic Membranes in the Care of Resistant Vascular Ulcers
NCT00820274
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stapling device
Efficacy of stapling device during radical cystectomy
Stapling device during radical cystectomy
Hemostasis
Ligasure Device
Efficacy of ligasure tissue sealing device during radical cystectomy
Ligasure tissue sealing device
Efficacy of tissue sealing device during hemostasis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stapling device during radical cystectomy
Hemostasis
Ligasure tissue sealing device
Efficacy of tissue sealing device during hemostasis
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male/Female gender
19 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
SChang
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sam S Chang, MD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
081018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.